General Information of Disease (ID: DISR6GKZ)

Disease Name Tuberous sclerosis 2
Synonyms TSC2 Angiomyolipomas, renal, modifier of; TSC2; tuberous sclerosis, type 2; tuberous sclerosis 2; tuberous sclerosis-2; tuberous sclerosis type 2
Definition Tuberous sclerosis mapped to chromosome 16p13.3 (TSC2 gene).
Disease Hierarchy
DISEMUGZ: Tuberous sclerosis
DISR6GKZ: Tuberous sclerosis 2
Disease Identifiers
MONDO ID
MONDO_0013199
MESH ID
C566021
UMLS CUI
C1860707
OMIM ID
613254
MedGen ID
348170

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 7 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
NTHL1 OTPQXPT1 Limited Altered Expression [1]
PKD1 OT5ALRZ5 Limited Biomarker [2]
RAP1GAP OTC31ONQ Limited Genetic Variation [3]
RHEB OTFLTSEC Limited Posttranslational Modification [4]
RNASE3 OTVE2XD1 Limited Biomarker [5]
TSC1 OTFF4YZ7 Strong Genetic Variation [6]
TSC2 OT47LWI9 Definitive Autosomal dominant [7]
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 DOT(s)

References

1 Suppression of tumor suppressor Tsc2 and DNA repair glycosylase Nth1 during spontaneous liver tumorigenesis in Long-Evans Cinnamon rats.Mol Cell Biochem. 2010 May;338(1-2):233-9. doi: 10.1007/s11010-009-0357-1. Epub 2009 Dec 24.
2 Insight into response to mTOR inhibition when PKD1 and TSC2 are mutated.BMC Med Genet. 2015 Jun 17;16:39. doi: 10.1186/s12881-015-0185-y.
3 Identification of tuberous sclerosis 2 messenger RNA splice variants that are conserved and differentially expressed in rat and human tissues.Cell Growth Differ. 1995 Sep;6(9):1185-91.
4 TSC2/Rheb signaling mediates ERK-dependent regulation of mTORC1 activity in C2C12 myoblasts.FEBS Open Bio. 2017 Jan 30;7(3):424-433. doi: 10.1002/2211-5463.12195. eCollection 2017 Mar.
5 ERK crosstalks with 4EBP1 to activate cyclin D1 translation during quinol-thioether-induced tuberous sclerosis renal cell carcinoma.Toxicol Sci. 2011 Nov;124(1):75-87. doi: 10.1093/toxsci/kfr203. Epub 2011 Aug 2.
6 Immunotherapy for Lymphangioleiomyomatosis and Tuberous Sclerosis: Progress and Future Directions.Chest. 2019 Dec;156(6):1062-1067. doi: 10.1016/j.chest.2019.08.005. Epub 2019 Aug 19.
7 The Gene Curation Coalition: A global effort to harmonize gene-disease evidence resources. Genet Med. 2022 Aug;24(8):1732-1742. doi: 10.1016/j.gim.2022.04.017. Epub 2022 May 4.